NCT00254475View on ClinicalTrials.gov

A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia

PHASE3CompletedINTERVENTIONAL
Enrollment

871

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Essential HypertensionHypercholesterolemia
Interventions
DRUG

simvastatin

DRUG

valsartan

Trial Locations (2)

Unknown

Investigative Centers

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00254475 - A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia | Biotech Hunter | Biotech Hunter